Skip to main content
Top

International Journal of Clinical Oncology

Issue 7/2025

Content (17 Articles)

How to report and discuss subgroup analyses in clinical practice guidelines? Evaluation procedure of the clinical and statistical relevancy

Kiichiro Ninomiya, Satoru Miura, Yuko Oya, Tomohiro Sakamoto, Kentaro Tanaka, Shunsuke Teraoka, Masahiro Morise, Satoshi Morita

Multidisciplinary treatment for advanced gastric cancer

Shingo Kanaji, Naoki Urakawa, Hitoshi Harada, Taro Ikeda, Yasufumi Koterazawa, Tomoaki Aoki, Ryuichiro Sawada, Yasunori Otowa, Hironobu Goto, Hiroshi Hasegawa, Kimihiro Yamashita, Takeru Matsuda, Yoshihiro Kakeji

Guidance on the short hydration method for cisplatin administration

Kiichiro Ninomiya, Kei Kunimasa, Yasuko Kurata, Yuki Sato, Yasuhito Fujisaka, Hitoshi Ishikawa, Katsuyuki Hotta

Distant parenchymal recurrence during long-term use of TTFields treatment for glioblastoma

Yuhei Takido, Fumiharu Ohka, Shoichi Deguchi, Kazuya Motomura, Koichi Mitsuya, Kosuke Aoki, Yoshiki Shiba, Kazuhito Takeuchi, Yuichi Nagata, Junya Yamaguchi, Yuji Kibe, Yutaro Fuse, Sachi Maeda, Hiroki Shimizu, Ryuta Saito

CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection

Kyoto Matsudo, Kazuki Takada, Asato Hashinokuchi, Taichi Nagano, Fumihiko Kinoshita, Takaki Akamine, Mikihiro Kohno, Tomoyoshi Takenaka, Mototsugu Shimokawa, Yoshinao Oda, Tomoharu Yoshizumi

Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan

Yusa Togashi, Masayuki Nagahashi, Aoi Oshiro, Gen Sugimoto, Ayumu Mitsuyoshi, Haruka Kanaoka, Akira Hattori, Junko Tsuchida, Tomoko Higuchi, Arisa Nishimukai, Yasuo Miyoshi

Primary tumor location is a risk factor for postoperative development of sarcopenia as a predictive marker for unfavorable outcomes in patients with colorectal cancer

Shinya Abe, Hiroaki Nozawa, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Hiroyuki Matsuzaki, Yuzo Nagai, Takahide Shinagawa, Hirofumi Sonoda, Soichiro Ishihara

Significance of preoperative mean corpuscular volume in patients with stage II/III colorectal cancer and anemia

Shuhei Asai, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka, Koji Shibata, Junichi Takamizawa, Norihiro Yuasa

Personalized prognostic model for colorectal cancer in the era of precision medicine: a dynamic approach based on real-world data

Keisuke Okura, Keita Fukuyama, Satoru Seo, Hiroto Nishino, Tomoaki Yoh, Norihiro Shimoike, Takahiro Nishio, Yukinori Koyama, Satoshi Ogiso, Takamichi Ishii, Koya Hida, Shigemi Matsumoto, Manabu Muto, Satoshi Morita, Kazutaka Obama, Etsuro Hatano

Clinical usefulness of nutritional and immunological indices to distinguish gallbladder carcinoma from benign disease

Daisuke Ogawa, Hiromitsu Hayashi, Shinsei Yumoto, Rumi Itoyama, Yuki Kitano, Shigeki Nakagawa, Hirohisa Okabe, Masaaki Iwatsuki

Contrast-enhanced ultrasound imaging characteristics of intrahepatic cholangiocarcinoma with actionable gene variants detected by comprehensive cancer gene panel testing

Kazunori Nakaoka, Eizaburo Ohno, Seiji Yamada, Teiji Kuzuya, Tamotsu Sudo, Sayaka Ueno, Hiroyuki Tanaka, Yutaka Sasaki, Ryoji Miyahara, Senju Hashimoto, Yoshiki Hirooka

Outcomes of capecitabine plus temozolomide combination therapy in patients with advanced or metastatic pancreatic neuroendocrine tumors: a retrospective observational single-center study

Yukiko Hibino, Susumu Hijioka, Chigusa Morizane, Daiki Agarie, Kohei Okamoto, Daiki Yamashige, Shin Yagi, Soma Fukuda, Masaru Kuwada, Yasuhiro Komori, Mao Okada, Yuta Maruki, Yoshikuni Nagashio, Hideki Ueno, Takuji Okusaka

Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study

Tomokazu Sazuka, Rikiya Taoka, Jun Miki, Ryoichi Saito, Wataru Fukuokaya, Yoshiyuki Matsui, Shingo Hatakeyama, Takashi Kawahara, Ayumu Matsuda, Taketo Kawai, Minoru Kato, Takeshi Sano, Fumihiko Urabe, Soki Kashima, Hirohito Naito, Yoji Murakami, Makito Miyake, Kei Daizumoto, Yuto Matsushita, Takuji Hayashi, Junichi Inokuchi, Yusuke Sugino, Kenichiro Shiga, Noriya Yamaguchi, Shingo Yamamoto, Keiji Yasue, Takashige Abe, Shotaro Nakanishi, Katsuyoshi Hashine, Atsuro Sawada, Kiyoaki Nishihara, Hiroaki Matsumoto, Shuichi Tatarano, Koichiro Wada, Sho Sekito, Ryo Maruyama, Naotaka Nishiyama, Hiroyuki Nishiyama, Hiroshi Kitamura, Tomohiko Ichikawa

Impact of obesity on the outcomes and cost of robotic surgery for Stage IA endometrial cancer: a regional perspective from Japan

  • Open Access
  • Obesity
  • Original Article

Mika Mizuno, Shinichi Togami, Mai Nakazono, Yuriko Higashi, Nozomi Furuzono, Mika Fukuda, Hiroaki Kobayashi

Case simulations: Biomarker-driven management of NSCLC (Link opens in a new window)

Do you want to assess your biomarker testing skills and management decisions? Use these simulation-based case studies based on realistic NSCLC scenarios to do so in a practical and secure environment.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
COMMISSIONED

How-to guide for healthcare professionals: understanding genomic reports

This educational activity was initiated, funded and co-developed by Boehringer Ingelheim and is intended for healthcare professionals in the UK and Ireland only. 

Genomic testing helps inform cancer diagnosis, prognosis, and treatment. A genomic report is generated by the laboratory carrying out next-generation sequencing to analyze biopsy samples. Access this educational microsite to learn more about typical genomic report content and how to interpret test results for patients with cancer.

NP-GB-106631 | Jan 2026

Commissioned by:
  • Boehringer Ingelheim
Learn more
Image Credits
Biomarker-driven management of NSCLC logo/© Springer Health+ IME, DNA double helix structure on a purple background/© 2025 Adobe